The WHO on Monday called for increased access to quality diabetes education for healthcare workers, the public and people living with diabetes as part of efforts to ensure better access to quality and affordable care for the disease. Globally, around 422 million people have diabetes, and 1.5 million deaths are directly attributed to diabetes every year, Dr Poonam Khetrapal Singh, WHO Regional Director for South-East Asia, said on the World Diabetes Day. In the WHO South-East Asia Region, more than 96 million people are estimated to have diabetes, and another 96 million to be pre-diabetic, causing at least 600,000 deaths annually, she said. "By 2045, unless urgent action is taken, the prevalence of diabetes in the region is expected to increase by 68 per cent," Singh said in a statement. Diabetes is a chronic metabolic disease. If detected late or improperly managed, it can lead to serious and life-threatening damage to the heart, blood vessels, eyes, kidneys and nerves. The risk o
Hans Kluge, regional director for Europe at the World Health Organization (WHO), called the current response to climate change "dangerously inconsistent and far too slow" in a statement
Delhi government has ordered WFH for 50 per cent of govt staffers, primary schools have been ordered shut
In wake of WHO's Global TB Report 2022, that notes the impact of Covid on diagnosis, treatment and burden of disease for TB all over, India said that the country has performed better on major metrics
While the new Covid variants are causing fear worldwide, in India, they do not lead to more hospital admissions and deaths. Though it is considered mild, the new variants are still fast-spreading ones
Swaminathan was speaking to reporters on Thursday on the sidelines of the annual general meeting of the Developing Countries Vaccine Manufacturers Network (DCVMN) here
With India reporting a highly infectious new COVID-19 variant, WHO scientist Soumya Swaminathan said that there were over 300 sub-variants and XBB being a recombinant virus is a matter of concern
The World Health Organization (WHO) said that Covid-19 is still a Public Health Emergency of International Concern (PHEIC), the WHO's highest alert level.
The DENV-2 variant has caused a rapid surge in dengue fever and death cases in Panchkula, Haryana
Centre forms panel to analyse causal relation between deaths and cough syrups
World Health Organisation has called on the member states in the South-East Asia Region to intensify action to achieve access for all to quality mental health care
The WHO's recent alert linking cough syrups manufactured by an Indian pharmaceutical firm to the deaths of children in Gambia is "alarming" and there are some missing links that need to be "investigated", an expert said on Saturday. The World Health Organisation on Wednesday issued an alert, saying four "contaminated" and "substandard" cough syrups produced by Maiden Pharmaceuticals Limited could be the reason for the deaths in the West African nation. The four products are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup. "The information from WHO that cough syrups manufactured by an Indian pharma company caused the death of 66 children due to the presence of ethylene glycol is alarming. "There are, however, some missing links that need to be carefully ascertained and investigated," said Professor Y K Gupta, senior pharmacologist and vice chairman of the Standing National Committee on Medicines (SNCM). Dr Gupta said the firs
Gambia has launched an urgent door-to-door campaign to remove cough and cold syrups blamed for the deaths of more than 60 children from kidney injury in the tiny West African country. Speaking to The Associated Press, the Director of Health Dr. Mustapha Bittaye confirmed the wave of child deaths from acute kidney injury, sending shockwaves across the country of 2.4 million people and around the world. The World Health Organisation has issued an alarm in response to the deaths. WHO has issued a medical product alert for four contaminated medicines identified in The Gambia that have been potentially linked to acute kidney injuries and 66 deaths among children, WHO Director-General Tedros Adhanom Ghebreyesus said in a statement issued on Wednesday. The loss of young lives is beyond heartbreaking for their families, he said. The four medicines are cough and cold syrups produced in India, said the WHO statement. While the contaminated products have so far only been detected in Gambia,
Samples of four cough syrups manufactured by a Sonipat-based firm have been sent to the Central Drugs Laboratory in Kolkata for examination, Haryana's Health Minister Anil Vij said Thursday, a day after the WHO potentially linked them to the deaths of 66 children in The Gambia. The World Health Organization (WHO) on Wednesday warned that four "contaminated" and "substandard" cough syrups allegedly produced by Maiden Pharmaceuticals Limited based in Haryana's Sonepat could be the reason for the deaths of children in the West African nation. A probe has already been initiated by India's drug regulator, the Drugs Controller General of India. "The samples have been collected by a team of the DCGA and Haryana's Food and Drugs Administration Department and sent to the CDL, Kolkata for examination," Vij told PTI over phone on Thursday. He said a senior official of Centre's Department of Pharmaceuticals spoke with Haryana's Additional Chief Secretary (Health). Vij said the cough syrups ..
After the World Health Organization issued an alert on four India-made cough and cold syrups used for paediatric groups, the Central Drugs Standard Control Organisation has taken up an urgent probe
WHO has asked not to use these four products until analysed by the relevant national regulatory authorities
Maiden Pharma has manufactured and exported the products only to Gambia so far
Bahl joined WHO in 2003 where he coordinates research and guidelines development in areas of maternal, newborn, child and adolescent health; was earlier with AIIMS
Snakebite envenoming (SBE) was added to the list of Neglected Tropical Diseases in 2017 by the World Health Organisation (WHO), which also estimates that there are 4.5-5.4 million snakebites worldwide
The World Health Organisation has expressed fears about an impending second disaster of water-borne diseases in Pakistan in the wake of devastating floods that has wreaked havoc in several parts of the country. In a statement issued by the WHO chief Tedros Adhanom Ghebreyesus, the global health watchdog said that water supply was disrupted in flood-hit areas of Pakistan, forcing people to drink unsafe water which could cause cholera and other diseases. The WHO has cautioned people across flood-hit areas of Pakistan, precisely the worst affected Sindh province to be extra careful. Tedros on Saturday highlighted that stagnant water serves as a breeding ground for mosquitoes and spreads vector-borne diseases such as malaria and dengue and urged donors to continue to respond generously to save lives and prevent more suffering. Separately, the WHO Director general tweeted that he was deeply concerned about the potential for a 2nd disaster in Pakistan, spreading disease and threatening .